Objective:We studied fetal endothelial function in a model of preeclampsia induced by Nω-nitro-L-arginine methylester (L-NAME) administration in pregnant rats.
Methods:Aortic segments from term fetuses and 2-day-old Wistar rats treated with L-NAME (0.5 mg/mL in drinking water) (fetuses from hypertensive rats, FH, and newborns from hypertensive rats, NH) and from untreated rats (fetuses from normotensive rats, FN, and newborns from normotensive rats, NN) were obtained. Endothelium-dependent and -independent relaxations were determined by the response to 1 μM acetylcholine (ACh) and 1 μM sodium nitroprusside (SNP), respectively, after precontraction with 3 μM prostaglandin F2α. The role of nitric oxide in ACh relaxation was assessed by incubation with 0.1 mM NG-monomethyl-L-arginine (L-NMMA) or 0.1 mM L-arginine (L-Arg). Precontraction with 50 mM ptoassium chloride assessed the role of hyperpolarizing mechanisms.
Results:In FH, ACh-induced relaxation was reduced (FH 34.2 ± 4%, FN 45.8 ± 2%, P < .05), whereas that of SNP was enhanced (FH 68.4 ± 5%, FN 50.4 ± 4%, P < .05). L-Arg did not reverse the impirment of ACh relaxation. L-NMMA reduced ACh relaxation in FN but increased it in FH; this increase was abolished by potassium chloride precontraction and by 1 μM capsaicine, a calcitonin-gene related peptide inhibitor. The hyperpolarizing component of ACh relaxation was reduced in FH as compared with FN. By contrast, ACh relaxation was greater in NH than in NN, with the relative participation of nitric oxide and hyperpolarizing-related components being similar in both groups.
Conclusion:Fetal ACh relaxation was impaired in this preeclampsia-like model. This impairment is probably not exclusively an effect of L-NAME but could reflect endothelial dysfunction that disappears after birth.
1. Naeye RL, Friedman EA. CAuses of perinatal death associated with gestational hypertension and proteinuria. Am J Obstet Gynecol1979;133:8-10.
2.
2. Brazy JE, Grimm JK, Little VA. Neonatal manifestations of severe maternal hypertension ocurring before the thirty-sixth week of pregnancy. J Pediatr1982;100:265-271.
3.
3. Hartikainen AL, Aliharmi RH, Rantakallio PT. A cohort study of epidemiological associations and outcomes of pregnancies with hypertensive disorders. Hypertens Pregn1998;17:31-41.
4.
4. Martínez-Orgado J, Guardia-Nieto L, Cueto-Calvo E, Lozano-Maneiro L, Martínez MC, Torres-Martí J. Influencia del tipo de estado hipertensivo del embarazo en la aparición de complicationes neonatales. Rev Esp Pediatr1998;54:379-385.
5.
5. Jacobson SL, Imhof R, Manning R, Mannion V, Little D, Rey E. The value of Doppler assessment of the uteroplacental circulation in predicting preeclampsia or intrauterine growth retardation. Am J Obstet Gynecol1990;162:110-114.
6.
6. Jouppila P, Kirkinen P. Blood velocity waveforms of the fetal aorta in normal and hypertensive pregnancies. Obstet Gynecol1986;67:856-860.
7.
7. Bush KD, O'Brien JM, Barton JR. The utility of umbilical artery Doppler investigation in women with the HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome. Am J Obstet Gynecol2001;184:1087-1089.
8.
8. Martikainen AM, Heinonen KM, Saarikoski SV. The effect of the hypertension in pregnancy on fetal and neonatal condition. Int J Gynaecol Obstet1998;30:213-220.
9.
9. Zeeman GG, Dekker GA. Pathogenesis of preeclampsia: A hypothesis. Clin Ob;stet Gynecol1992;35:317-337.
10.
10. Roberts MJ, Redman CWG. Preeclampsia: More than pregnancy-induced hypertension. Lancet1993;341:1447-1451.
11.
11. Friedman SA, Schiff E, Emeis JJ, Dekker GA, Sibai BM. Biochemical corroboration of endothelial involvement in severe preeclampsia. Am J Obstet Gynecol1995;172:202-203.
12.
12. Davidge ST, Signorella AP, Hubel CA, Lykins DL, Roberts JM. Distinct factors in plasma of preeclamptic women increase endothelial nitric oxide and prostacyclin. Hypertension1996;28:758-764.
13.
13. Davidge ST, Signorella AP, Lykins DL, Gilmour CH, Roberts JM. Evidence of endothelial activation and endothelial activators in cord blood of infants of preeclamptic women. Am J Obstet Gynecol1996;175:1301-1306.
14.
14. McCarthy AL, Woolfson RG, Raju SK, Poston L. Abnormal endothelial cell function of resistance arteries from women with preeclampsia. Am J Obstet Gynecol1993;168:1323-1330.
15.
15. Rutherford RAD, McCarthy A, Sullivan MHF, Elder MG, Polak JM, Wharton J. Nitric oxide synthase in human placenta and umbilical cord from normal, intrauterine growth-retarded and pre-eclamptic pregnancies. Br J Obstet Gynaecol1995;116:3099-3109.
16.
16. Steinert JR, Wyatt AW, Poston L, Jacob R, Mann GE. Preeclampsia is associated with altered Ca2+ regulation and NO production in human fetal venous endothelial cells. FASEB J2002;16:721-723.
17.
17. Knock GA, Poston L. Bradykinin-mediated relaxation in isolated maternal resistance arteries in normal pregnancy and preeclampsia. Am J Obstet Gynecol1996;175:1668-1674.
18.
18. Pinto A, Sorrentino R, Sorrentino P, Guerritore T, Miranda L, Biondi A. Endothelial-derived relaxing factor released by endothelial cells of human umbilical vessel and its impairment in pregnancy-induced hypertension. Am J Obstet Gynecol1991;164:507-513.
19.
19. Arias F. ACcuracy of the middle-cerebral-to-umbilical-artery resistance index ratio in the prediction of neonatal outcome in patients at high risk for fetal and neonatal complications. Am J Obstet Gynecol1994;171:1541-1545.
20.
20. Molnár M, Sütö T, Tóth T, Hertelendy F. Prolonged blockade of nitric oxide synthase in gravid rats produces sustained hypertension, proteinuria, thrombocytopenia, and intrauterine growth retardation. Am J Obstet Gynecol1994;170:1458-1466.
21.
21. Martínez-Orgado J, González R, Tovar S, Marín J, Salaices M, Alonso MJ. Administration of Nω-L-arginine methylester (L-NAME) impairs endothelium-dependent relaxation in gravid but not in non-gravid rats. J Soc Gynecol Investig2003;2:74-81.
22.
22. Martínez-Orgado J, González R, Alonso MJ, Marín J. Nitric oxide-dependent and -independent mechanisms in the relaxation elicited by acetylocholine in fetal rat aorta. Life Sci1999;64:269-277.
24. Hishikawa K, Kakaki T, Suzuki H, Kato R, Saruta T. Role of L-arginine: Nitric oxide pathway in hypertension. J Hypertens1993;11:639-645.
25.
25. Marín J, Rodríguez-Martínez MA. Role of vascular nitric oxide in physiological and pathological conditions. Pharmacol Ther1997;75:111-134.
26.
26. Zhao H, Shimokawa H, Uragami-Harasawa L, Igarashi H, Takeshita A. Long-term vascular effects of Nω-nitro-L-arginine methyl ester are not solely mediated by inhibition of endothelial nitric oxide synthesis in the rat mesenteric artery. J Cardiovasc Pharmacol1999;33:554-566.
27.
27. Corriu C, Feletou M, Puybasset L, Bea ML, Berdeaux A, Vanhoutte PM. Endothelium-dependent hyperpolarization in isolated arteries taken from animals treated with NO-synthase inhibitors. J Cardiovasc Pharmacol1998;32:944-950.
28.
28. Bauersachs J, Popp R, Hecker M, Sauer E, Fleming I, Busse R. Nitric oxide attenuates the release of entoehelium-derived hyperpolarizing factor. Circulation1996;94:3341-3347.
29.
29. Maeso R, Navarro-Cid J, Rodrigo E, Ruilope LM, Cachofeiro V, Lahera V. Effects of antihypertensive therapy on factors mediating endothelium-dependent relaxation in rats treated chronically with L-NAME. J Hypertens1999;17:221-227.
30.
30. Gangula PR, Supowit SC, Wimalawansa SJ, et al. Calcitonin gene-related peptide is a depressor in NG-intro-L-arginine methyl ester-induced hypertension during pregnancy. Hypertension1997;29:248-253.
31.
31. Voelker CA, Miller MJ, Zhang XJ, Eloby-childress S, Clark DA, Pierce MJ. Perinatal nitric oxide synthase inhibition retards neonatal growth by inducing hypetrophic pyloric stenosis in rats. Pediatr Res1995;35:768-774.
32.
32. Pearce WJ, Longo LD. Development aspects of endothelial function. Semin Perinatol1991;15:40-48.
